Accentia Biopharmaceuticals, Inc. (NASDAQOTH:ABPI.PK)

CAPS Rating No stars 
ABPI.PK VS S&P 500 (SPY)

ABPI.PK News and Commentary

Related News and Articles

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

35 Outperform
6 Underperform
 

All-Star Players

8 Outperform
2 Underperform
 

Wall Street

0 Outperform
1 Underperform
 

Top ABPI.PK Bull/Bear Pitches

gingerlade (< 20)
Submitted December 29, 2007

The company has a few blockbuster biopharmaceuticals in the pipeline awaitingfast track and FDA approval...SinuNase (BDSI)andRevimmune for 80 autoimmune diseases focusingfor now on relapse-remit MS....and a vaccinefor Hodgkins Lymphoma and a Biovac… More

Fools bullish on ABPI.PK
are also bullish on:

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Featured Broker Partners


Advertisement